{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T21:49:27Z","timestamp":1778708967772,"version":"3.51.4"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1097\/md.0000000000009964","type":"journal-article","created":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T17:33:38Z","timestamp":1519234418000},"page":"e9964","source":"Crossref","is-referenced-by-count":15,"title":["Urinary metalloproteinases and tissue inhibitors of metalloproteinases as potential early biomarkers for renal fibrosis in children with nephrotic syndrome"],"prefix":"10.1097","volume":"97","author":[{"given":"Beata","family":"Bienia\u015b","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Przemys\u0142aw","family":"Sikora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-57-20210309","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function and biochemistry","volume":"92","author":"Visse","year":"2003","journal-title":"Circ Res"},{"key":"R2-57-20210309","doi-asserted-by":"crossref","first-page":"F905","DOI":"10.1152\/ajprenal.00421.2006","article-title":"Role of matrix metalloproteinases in renal pathophysiologies","volume":"292","author":"Catania","year":"2007","journal-title":"Am J Ren Physiol"},{"key":"R3-57-20210309","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cardiores.2005.12.002","article-title":"Structure and function of matrix metalloproteinases and TIMPs","volume":"69","author":"Nagase","year":"2006","journal-title":"Cardiovasc Res"},{"key":"R4-57-20210309","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s004670000461","article-title":"Molecular basis of renal fibrosis","volume":"15","author":"Eddy","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"R5-57-20210309","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2353\/ajpath.2010.090188","article-title":"Macrophage matrix metalloproteinase-9 mediates epithelial-mesenchymal transition in vitro in murine renal tubular cells","volume":"176","author":"Tan","year":"2010","journal-title":"Am J Pathol"},{"key":"R6-57-20210309","first-page":"307","article-title":"Matrix metalloproteinases and their role in the renal epithelial mesenchymal transition","volume":"26","author":"Aresu","year":"2011","journal-title":"Histol Histopathol"},{"key":"R7-57-20210309","doi-asserted-by":"crossref","first-page":"21712","DOI":"10.1016\/S0021-9258(19)36670-0","article-title":"Matrix metalloproteinase 9 (92-kDa gelatinase\/type IV collagenase) from HT 1080 human fibrosarcoma cells: purification and activation of the precursor and enzymic properties","volume":"267","author":"Okada","year":"1992","journal-title":"J Biol Chem"},{"key":"R8-57-20210309","doi-asserted-by":"crossref","first-page":"10672","DOI":"10.1074\/jbc.273.17.10672","article-title":"High affinity binding of latent matrix metalloproteinase-9 to the alpha2(IV) chain of collagen IV","volume":"273","author":"Olson","year":"1998","journal-title":"J Biol Chem"},{"key":"R9-57-20210309","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ceb.2009.06.006","article-title":"Matrix metalloproteinase proteomics: substrates, targets, and therapy","volume":"21","author":"Morrison","year":"2009","journal-title":"Curr Opin Cell Biol"},{"key":"R10-57-20210309","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1385\/MB:22:1:051","article-title":"Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites","volume":"22","author":"Overall","year":"2002","journal-title":"Mol Biotechnol"},{"key":"R11-57-20210309","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ki.1996.10","article-title":"Tubular gelatinase A (MMP-2) and its tissue inhibitors in polycystic kidney disease in the Han: SPRD rat","volume":"49","author":"Schaefer","year":"1996","journal-title":"Kidney Int"},{"key":"R12-57-20210309","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1432-2277.2004.00053.x","article-title":"Fibrosis and matrix metalloproteinases in rat renal allografts","volume":"18","author":"Inkinen","year":"2005","journal-title":"Transpl Int"},{"key":"R13-57-20210309","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10157-003-0258-7","article-title":"Decreased collagen-degrading activity could be a marker of prolonged mesangial matrix expansion","volume":"8","author":"Tomita","year":"2004","journal-title":"Clin Exp Nephrol"},{"key":"R14-57-20210309","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1074\/jbc.274.3.1614","article-title":"Matrix metalloproteinase 2 (MMP2) and MMP9 are produced by kidney collecting duct principal cells but are differentially regulated by SV40 large-T, arginine vasopressin, and epidermal growth factor","volume":"274","author":"Piedagnel","year":"1999","journal-title":"J Biol Chem"},{"key":"R15-57-20210309","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s10157-004-0289-8","article-title":"Expression of MMP-9 in mesangial cells and its changes in anti-GBM glomerulonephritis in WKY rats","volume":"8","author":"Kuroda","year":"2004","journal-title":"Clin Exp Nephrol"},{"key":"R16-57-20210309","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1523-1755.2005.00389.x","article-title":"Renal expression of SIBLING proteins and their partner matrix metalloproteinases (MMPs)","volume":"68","author":"Ogbureke","year":"2005","journal-title":"Kidney Int"},{"key":"R17-57-20210309","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0092-8674(02)01079-6","article-title":"Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury","volume":"111","author":"Li","year":"2002","journal-title":"Cell"},{"key":"R18-57-20210309","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0006-291X(03)01405-0","article-title":"Pro-MMP-9 activation by the MT1-MMP\/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes","volume":"308","author":"Toth","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"R19-57-20210309","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/labinvest.2013.3","article-title":"Matrix metalloproteinase-9 of tubular and macrophage origin contributes to the pathogenesis of renal fibrosis via macrophage recruitment through osteopontin cleavage","volume":"93","author":"Tan","year":"2013","journal-title":"Lab Invest"},{"key":"R20-57-20210309","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.clinbiochem.2011.03.143","article-title":"Peripheral blood level alterations of MMP-2 and MMP-9 in patients with chronic kidney disease on conservative treatment and on hemodialysis","volume":"44","author":"Pawlak","year":"2011","journal-title":"Clin Biochem"},{"key":"R21-57-20210309","first-page":"811","article-title":"Role of matrix metalloproteinases in the progression of renal lesions","volume":"29","author":"Marti","year":"2000","journal-title":"Presse Med"},{"key":"R22-57-20210309","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/1354750X.2015.1061598","article-title":"Urine survivin, E-cadherin and matrix metalloproteinases as novel biomarkers in children with chronic kidney disease","volume":"20","author":"Musia\u0142","year":"2015","journal-title":"Biomarkers"},{"key":"R23-57-20210309","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ki.1995.61","article-title":"Effect of a specific endothelin A receptor antagonist on murine lupus nephritis","volume":"47","author":"Nakamura","year":"1995","journal-title":"Kidney Int"},{"key":"R24-57-20210309","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1172\/JCI118502","article-title":"Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy","volume":"97","author":"McMillan","year":"1996","journal-title":"J Clin Invest"},{"key":"R25-57-20210309","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0272-6386(96)90127-4","article-title":"Increased mRNA expression of metalloproteinase-9 in peripheral blood monocytes from patients with immunoglobulin A nephropathy","volume":"28","author":"Koide","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"R26-57-20210309","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jdiacomp.2007.10.002","article-title":"The kidney expression of matrix metalloproteinase-9 in the diabetic nephropathy of Kkay mice","volume":"22","author":"Qing-Hua","year":"2008","journal-title":"J Diabetes Complications"},{"key":"R27-57-20210309","first-page":"163","article-title":"Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO Clinical Practice Guideline for Glomerulonephritis.","volume":"2","author":"Kidney","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"R28-57-20210309","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/sj.ki.5002108","article-title":"Localization of matrix metalloproteinases and their inhibitors in experimental progressive kidney scarring","volume":"71","author":"Ahmed","year":"2007","journal-title":"Kidney Int"},{"key":"R29-57-20210309","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/ki.1996.161","article-title":"Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy","volume":"49","author":"Ishidoya","year":"1996","journal-title":"Kidney Int"},{"key":"R30-57-20210309","first-page":"754","article-title":"Altered expression of matrix metalloproteinase-2, TIMP, and TIMP-2 in obstructive nephropathy","volume":"125","author":"Sharma","year":"1995","journal-title":"J Lab Clin Med"},{"key":"R31-57-20210309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trim.2013.11.004","article-title":"Correlation of serum and urinary matrix metalloproteases\/tissue inhibitors of metalloproteases with subclinical allograft fibrosis in renal transplantation","volume":"30","author":"Hirt-Minkowski","year":"2014","journal-title":"Transpl Immunol"},{"key":"R32-57-20210309","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1097\/HJH.0b013e3283614c1c","article-title":"Circulating biomarkers of collagen metabolism in arterial hypertension: relevance of target organ damage","volume":"31","author":"Morillas","year":"2013","journal-title":"J Hypertens"},{"key":"R33-57-20210309","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000339645","article-title":"Urinary matrix metalloproteinase activity in diabetic kidney disease: a potential marker of disease progression","volume":"2","author":"Altemtam","year":"2012","journal-title":"Nephron Extra"},{"key":"R34-57-20210309","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.clinbiochem.2010.02.006","article-title":"Urinary matrix metalloproteinase-8 and -9 activities in type 2 diabetic subjects: a marker of incipient diabetic nephropathy?","volume":"43","author":"van der Zijl","year":"2010","journal-title":"Clin Biochem"},{"key":"R35-57-20210309","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.2337\/dc07-0162","article-title":"Matrix metalloproteinase-2 dysregulation in type 1 diabetes","volume":"30","author":"Thrailkill","year":"2007","journal-title":"Diabetes Care"},{"key":"R36-57-20210309","doi-asserted-by":"crossref","first-page":"F1326","DOI":"10.1152\/ajprenal.00267.2011","article-title":"Urinary matrix metalloproteinase activities: biomarkers for plaque angiogenesis and nephropathy in diabetes","volume":"301","author":"McKittrick","year":"2011","journal-title":"Am J Renal Physiol"},{"key":"R37-57-20210309","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1600-6143.2008.02512.x","article-title":"Renal allografts with IF\/TA display distinct expression profiles of metzincins and related genes","volume":"9","author":"R\u00f6dder","year":"2009","journal-title":"Am J Transplant"},{"key":"R38-57-20210309","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cca.2013.12.031","article-title":"Novel indicators of fibrosis-related complications in children with chronic kidney disease","volume":"430","author":"Musia\u0142","year":"2014","journal-title":"Clin Chim Acta"},{"key":"R39-57-20210309","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10495-012-0764-8","article-title":"New markers of apoptosis in children on chronic dialysis","volume":"18","author":"Musia\u0142","year":"2013","journal-title":"Apoptosis"},{"key":"R40-57-20210309","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s10495-011-0604-2","article-title":"Matrix metalloproteinases and soluble Fas\/FasL system as novel regulators of apoptosis in children and young adults on chronic dialysis","volume":"16","author":"Musia\u0142","year":"2011","journal-title":"Apoptosis"},{"key":"R41-57-20210309","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cca.2005.10.007","article-title":"Relationships between circulating matrix metalloproteinase-2 and -9 and renal function in patients with chronic kidney disease","volume":"366","author":"Chang","year":"2006","journal-title":"Clin Chim Acta"},{"key":"R42-57-20210309","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1096\/fj.06-5898fje","article-title":"Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury","volume":"20","author":"Cheng","year":"2006","journal-title":"FASEB J"},{"key":"R43-57-20210309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12020-008-9114-6","article-title":"Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy","volume":"35","author":"Thrailkill","year":"2009","journal-title":"Endocrine"},{"key":"R44-57-20210309","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11010-005-9005-6","article-title":"Increase in extracellular cross-linking by tissue transglutaminase and reduction in expression of MMP-9 contribute differentially to focal segmental glomerulosclerosis in rats","volume":"284","author":"Liu","year":"2006","journal-title":"Mol Cell Biochem"},{"key":"R45-57-20210309","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/ar2532","article-title":"Glomerular matrix metalloproteinases and their regulators in the pathogenesis of lupus nephritis","volume":"10","author":"Tveita","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"R46-57-20210309","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/sj.ki.5002715","article-title":"Urinary biomarkers in the early diagnosis of acute kidney injury","volume":"73","author":"Han","year":"2008","journal-title":"Kidney Int"},{"key":"R47-57-20210309","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1203\/PDR.0b013e3181ca0aa2","article-title":"Effects of metalloproteinase inhibition in a murine model of renal ischemia-reperfusion injury","volume":"67","author":"Novak","year":"2010","journal-title":"Pediatr Res"},{"key":"R48-57-20210309","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/ndt\/17.7.1189","article-title":"Glomerular distribution and gelatinolytic activity of matrix metalloproteinases in human glomerulonephritis","volume":"17","author":"Urushihara","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"R49-57-20210309","doi-asserted-by":"crossref","first-page":"e6129","DOI":"10.5812\/ijp.6129","article-title":"Potential of serum and urinary matrix metalloproteinase-9 levels for the early detection of renal involvement in children with Henoch-Schonlein purpura","volume":"26","author":"Erol","year":"2016","journal-title":"Iran J Pediatr"},{"key":"R50-57-20210309","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1046\/j.1523-1755.2000.00274.x","article-title":"TIMP-1 gene expression and PAI-1 antigen after unilateral ureteral obstruction in the adult male rat","volume":"58","author":"Duymelinck","year":"2000","journal-title":"Kidney Int"},{"key":"R51-57-20210309","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/ndt\/17.6.1005","article-title":"Elevation of serum and urine levels of TIMP-1 and tenascin in patients with renal disease","volume":"17","author":"Horstrup","year":"2002","journal-title":"Nephrol Dial Transplant"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000009964","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:57:33Z","timestamp":1620961053000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201802230-00057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000009964","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]}}}